Metastasis from oral cancer: an overview

J Noguti, CFG De Moura, GPP De Jesus… - Cancer genomics & …, 2012 - cgp.iiarjournals.org
Oral cancer is a common neoplasm worldwide. Its incidence and mortality have also
increased over the past decades. It is characterized by poor prognosis and a low survival …

A systematic review of proteomic biomarkers in oral squamous cell cancer

J Pillai, T Chincholkar, R Dixit, M Pandey - World Journal of Surgical …, 2021 - Springer
Background Head and neck squamous cell cancer (HNSCC) is the most common cancer
associated with chewing tobacco, in the world. As this is divided in to sites and subsites, it …

Identification of salivary metabolomic biomarkers for oral cancer screening

S Ishikawa, M Sugimoto, K Kitabatake, A Sugano… - Scientific reports, 2016 - nature.com
The objective of this study was to explore salivary metabolite biomarkers by profiling both
saliva and tumor tissue samples for oral cancer screening. Paired tumor and control tissues …

Downregulation of exosomal CLEC3B in hepatocellular carcinoma promotes metastasis and angiogenesis via AMPK and VEGF signals

W Dai, Y Wang, T Yang, J Wang, W Wu… - Cell communication and …, 2019 - Springer
Abstract Background C-Type Lectin Domain Family 3 Member B (CLEC3B), is down-
regulated in serum and tumor tissues in different cancers including hepatocellular …

A 13-gene signature prognostic of HPV-negative OSCC: discovery and external validation

P Lohavanichbutr, E Méndez, FC Holsinger… - Clinical Cancer …, 2013 - AACR
Purpose: To identify a prognostic gene signature for patients with human papilloma virus
(HPV)–negative oral squamous cell carcinomas (OSCC). Experimental Design: Two gene …

“Omics” in oral cancer: New approaches for biomarker discovery

V Rai, R Mukherjee, AK Ghosh, A Routray… - Archives of Oral …, 2018 - Elsevier
Objectives In this review paper, we explored the application of “omics” approaches in the
study of oral cancer (OC). It will provide a better understanding of how “omics” approaches …

CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment

J Sun, T Xie, M Jamal, Z Tu, X Li, Y Wu, J Li… - Cancer cell …, 2020 - Springer
Background Lung cancer is the leading cause of cancer-related mortality globally.
Discovering effective biomarkers for early diagnosis and prognosis is important to reduce …

FCN2 inhibits epithelial–mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling

G Yang, Y Liang, T Zheng, R Song, J Wang, H Shi… - Cancer letters, 2016 - Elsevier
Hepatocellular carcinoma (HCC) is currently still a major cause of cancer-related deaths.
Identifying early metastatic biomarkers and therapeutic targets for HCC is of great …

Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma

L Zhong, Y Liu, K Wang, Z He, Z Gong, Z Zhao, Y Yang… - BMC cancer, 2018 - Springer
Traditional therapeutics have encountered a bottleneck caused by diagnosis delay and
subjective and unreliable assessment. Biomarkers can overcome this bottleneck and guide …

Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family

J Peltier, JP Roperch, S Audebert, JP Borg… - Journal of Proteomics, 2016 - Elsevier
Colorectal cancer (CRC) remains a major cause of cancer related-death in developed
countries. The mortality risk is correlated with the stage of CRC determined at the primary …